Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28803958 | 0.89 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL22619982 | 0.89 | ALOX15 (0.46) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL3372776 | 0.87 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| Water SCHEMBL4000009 | 0.87 | MEN1 (0.44) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL29083077 | 0.87 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL11204020 | 0.87 | CYP4F2 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL125138 | 0.87 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL29756467 | 0.87 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL13807718 | 0.85 | SOAT1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| Fluoride SCHEMBL11204021 | 0.85 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10ALOX15MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119882351-A | High-adhesion positive KrF photoresist resin composition | 万华化学集团股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119320531-A | Corrosion-resistant power tube and preparation method thereof | 赣州祺琳新材料有限公司 | 2025-01-17 | — | — | CN | claimed |
| CN-117806124-A | Positive photosensitive polyimide resin composition | 万华化学集团股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| EP-4711365-A1 | THIAZOLE DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Hansoh Biomedical Co., Ltd. (CN) | 2026-03-18 | — | — | EP | disclosed |
| US-12559483-B2 | Process for the preparation of fluoxastrobin and intermediates thereof | UPL LTD (IN) | 2026-02-24 | — | — | US | disclosed |
| US-20250346613-A1 | BORIC ACID PROTEASOME INHIBITOR AND USE THEREOF | ARTIVILA BIOPHARMA (CN) | 2025-11-13 | — | — | US | disclosed |
| US-20250270209-A1 | LRRK2 INHIBITORS | INTERLINE THERAPEUTICS, INC. | 2025-08-28 | — | — | US | disclosed |
| US-20250188110-A1 | SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2025-06-12 | — | — | US | disclosed |
| CN-119320531-B | Corrosion-resistant power tube and preparation method thereof | 赣州祺琳新材料有限公司 | 2025-06-06 | — | — | CN | disclosed |
| CN-119954801-A | TAU protein targeting compounds and related methods of use | 阿尔维纳斯运营股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119882351-A | High-adhesion positive KrF photoresist resin composition | 万华化学集团股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-6174628-B1 | ELECTROLYTE HAS HIGH POLARITY, HIGH RESISTANCE TO OXIDATION AND FLAME RETARDANCE, AND THUS POSSESSES EXCELLENT CHARACTERISTICS AS THE ELECTROLYTE FOR ELECTRIC ENERGY GENERATORS | DAIKIN INDUSTRIES, LTD. (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-0833811-B1 | A PROCESS FOR THE PREPARATION OF ESTERS | F2 CHEMICALS LIMITED (GB) | 2000-04-05 | — | — | EP | disclosed |
| EP-0948073-A1 | ELECTROLYTIC SOLUTION AND DEVICE FOR GENERATING ELECTRIC ENERGY THEREWITH | Daikin Industries, Ltd. (JP) | 1999-10-06 | — | — | EP | disclosed |
| US-5847198-A | Process for the preparation of esters | F2 CHEMICALS LIMITED (GB) | 1998-12-08 | — | — | US | disclosed |
| EP-0833811-A1 | A PROCESS FOR THE PREPARATION OF ESTERS | BNFL FLUOROCHEMICALS LIMITED (GB) | 1998-04-08 | — | — | EP | disclosed |
| EP-0597329-B1 | Process for the preparation of alpha-fluor-beta dicarbonyle compounds | BAYER AG (DE) | 1997-02-05 | — | — | EP | disclosed |
| WO-1997000848-A1 | A PROCESS FOR THE PREPARATION OF ESTERS | BNFL FLUOROCHEMICALS LTD. (GB) | 1997-01-09 | — | — | WO | disclosed |
| US-5391811-A | Process for the preparation of α-fluoro-β-dicarbonyl compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1995-02-21 | — | — | US | disclosed |
| EP-0597329-A2 | Process for the preparation of alpha-fluor-beta dicarbonyle compounds | BAYER AG (DE) | 1994-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188110-A1 | SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION | KMT5A, KMT5B, KMT5C | ALDH1A1 2233/4885LMNA 3925/4885HSD17B10 2002/4885 |
| US-20250346613-A1 | BORIC ACID PROTEASOME INHIBITOR AND USE THEREOF | PSMA1, PSMB11, PSMB1 | ALDH1A1 2948/4885LMNA 2565/4885HSD17B10 2975/4885 |
| US-20250270209-A1 | LRRK2 INHIBITORS | LRRK2, PARK7, PINK1 | ALDH1A1 2142/4885LMNA 2763/4885HSD17B10 3433/4885 |
| US-12559483-B2 | Process for the preparation of fluoxastrobin and intermediates thereof | P2RX7, P2RX6, CTRB1 | ALDH1A1 920/4885LMNA 1078/4885HSD17B10 3567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.